Betaseron and Lidocaine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Betaseron (interferon beta-1b) and Lidocaine (lidocaine). Common drug interactions include asthenia among females and bradycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Betaseron and Lidocaine. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Betaseron?

Betaseron has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 26,886 Betaseron users. Check the latest studies of Betaseron.

What is Lidocaine?

Lidocaine has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 27,555 Lidocaine users. Check the latest studies of Lidocaine.

On Jul, 25, 2026

15 people who take Betaseron and Lidocaine together, and have interactions are studied.

Betaseron and Lidocaine drug interactions.

What are the common drug interactions of Betaseron and Lidocaine, by gender? *:

female:

Asthenia (weakness)
Bacterial infection
Bladder spasm
Dysarthria (speech disorder)
Dysphagia (a condition in which swallowing is difficult or painful)
Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
Gastric ulcer (stomach ulcer)
Hypersomnia (excessive daytime sleepiness (eds))
Hypokalaemia (low potassium)
Local swelling (swelling at the site of some application of substance or injury)

male:

Bradycardia (abnormally slow heart action)
Nodal rhythm (40-50 beats per minute)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Injection site pain
Mobility decreased (ability to move is reduced)

What are the common drug interactions of Betaseron and Lidocaine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Mood swings (an extreme or rapid change in mood)
Somnolence (a state of near-sleep, a strong desire for sleep)
Transient psychosis (short term loss of contact with reality)
Weight decreased
Headache (pain in head)
Acne (skin problems that cause pimples)
Acute psychosis (period of mentally unstable behaviour)
Aggression
Agitation (state of anxiety or nervous excitement)
Anaemia (lack of blood)

40-49:

Anaemia (lack of blood)
Asthenia (weakness)
Bacterial infection
Bladder spasm
Dysarthria (speech disorder)
Dysphagia (a condition in which swallowing is difficult or painful)
Fatigue (feeling of tiredness)
Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
Gastric ulcer (stomach ulcer)
Headache (pain in head)

50-59:

Chest pain
Defaecation urgency (a sudden compelling urge to defecate)
Dehydration (dryness resulting from the removal of water)
Drug abuse
Drug dependence
Drug effect decreased
Erythromelalgia (episodes of pain, redness, and swelling in various parts of the body)
Fall
Fear
Grip strength decreased

60+:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Injection site pain
Mobility decreased (ability to move is reduced)

What are the existing conditions these people have? *

Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 2 people, 13.33%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 13.33%
Sinusitis (inflammation of sinus): 1 person, 6.67%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 6.67%
Muscle Spasms (muscle contraction): 1 person, 6.67%
Medical Device Complication: 1 person, 6.67%
Joint Stiffness: 1 person, 6.67%
Immunodeficiency: 1 person, 6.67%
Erythromelalgia (episodes of pain, redness, and swelling in various parts of the body): 1 person, 6.67%
Dyspnea (difficult or laboured breathing): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Betaseron and Lidocaine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously